4G/5G PAI-1 Promoter Polymorphism and Acute-Phase Levels of PAI-1 Following Coronary Bypass Surgery: A Prospective Study

By Burzotta Francesco   Iacoviello Licia   Di Castelnuovo Augusto   Zamparelli Roberto   D'Orazio Andria   Amore Concetta   Schiavello Rocco   Donati Maria Benedetta   Maseri Attilio   Possati GianFederico   Andreotti Felicita  

Journal of Thrombosis and Thrombolysis, Vol. 16, Iss. 3, 2003-12 ,pp. : 149-154

Springer Publishing Company

Access to resources Recommend Favorite

Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G polymorphism and metabolic/proinflammatory factors in polycystic ovary syndrome

By Sales MF   Sóter MO   Candido AL   Fernandes AP   Oliveira FR   Ferreira ACS   Sousa MO   Ferreira CN   Gomes KB  

Gynecological Endocrinology, Vol. 29, Iss. 10, 2013-10 ,pp. : 936-939

Informa Healthcare

Access to resources Recommend Favorite

An Effect of the PAI-1 4G/5G Polymorphism on Cholesterol Levels May Explain Conflicting Associations with Myocardial Infarction and Stroke

By  

Cerebrovascular Diseases, Vol. 22, Iss. 2-3, 2006-07 ,pp. : 191-195

Karger

Access to resources Recommend Favorite

PAI-I 4G/5G polymorphism and sudden cardiac death in patients with coronary artery disease

By Anvari A.   Schuster E.   Gottsauner-Wolf M.   Wojta J.   Huber K.  

Thrombosis Research, Vol. 103, Iss. 2, 2001-07 ,pp. : 103-107

Elsevier

Access to resources Recommend Favorite

Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in cancer patients with and without thrombosis

By Eroglu Aydan   Ulu Arzu   Akar Nejat  

Journal of Thrombosis and Thrombolysis, Vol. 22, Iss. 2, 2006-10 ,pp. : 111-112

Springer Publishing Company

Access to resources Recommend Favorite